Your session is about to expire
← Back to Search
Ischemic Conditioning for Frailty
Phase 2
Recruiting
Research Sponsored by Medical College of Wisconsin
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 0.5 hours
Summary
This trial looks at how small blood vessels respond to exercise and if a safe intervention can protect them. Participants will come in for 3 visits and do home-based ischemic conditioning.
Who is the study for?
This trial is for men and women aged 65-85 who may be experiencing frailty or have poor blood vessel function. Participants should be able to perform high-intensity exercise and commit to three study visits along with home-based treatments using a blood pressure cuff.
What is being tested?
The trial tests ischemic conditioning, which involves temporarily restricting blood flow with a cuff, to see if it can protect small blood vessels from stress during high-intensity exercise in older adults.
What are the potential side effects?
Potential side effects of ischemic conditioning could include discomfort or bruising where the cuff is applied, temporary numbness, tingling in the arm, or muscle fatigue.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 0.5 hours
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~0.5 hours
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in Acetylcholine-mediated dilation
Change in Perfused Vessel Density
Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Ischemic Conditioning-HighExperimental Treatment1 Intervention
We will use a randomized block design to randomize individuals into either Ischemic Conditioning-Low or Ischemic Conditioning-High group using an online randomizer. A handheld sphygmomanometer and blood pressure cuff will be given to study participants. For the Ischemic Conditioning-High group participants, while sitting, the cuff will be placed around the non-dominant upper arm and inflated to 225 mmHg for 5 min, then released for a 5-min recovery period. A 5-min inflation period is most used. Five cycles of inflation/recovery will be performed. All participants will perform the intervention daily for 2 weeks. Participants will complete daily log sheets documenting the time and pressure of each cuff inflation.
Group II: Ischemic Conditioning-LowPlacebo Group1 Intervention
We will use a randomized block design to randomize individuals into either Ischemic Conditioning-Low or Ischemic Conditioning-High group using an online randomizer. A handheld sphygmomanometer and blood pressure cuff will be given to study participants. For the Ischemic Conditioning-Low group participants, while sitting, the cuff will be placed around the non-dominant upper arm and inflated to 10 mmHg for 5 min, then released for a 5-min recovery period. A 5-min inflation period is most used. Five cycles of inflation/recovery will be performed. All participants will perform the intervention daily for 2 weeks. Participants will complete daily log sheets documenting the time and pressure of each cuff inflation.
Find a Location
Who is running the clinical trial?
Medical College of WisconsinLead Sponsor
628 Previous Clinical Trials
1,179,816 Total Patients Enrolled
3 Trials studying Aging
414 Patients Enrolled for Aging
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have had blood clots in my arms or legs.My high blood pressure is not under control.My BMI is over 40.I have had a heart attack in the last 6 months.I have a history of heart failure.I don't have any conditions that prevent arm compression or temporary reduced blood flow.I am between 65 and 85 years old.
Research Study Groups:
This trial has the following groups:- Group 1: Ischemic Conditioning-Low
- Group 2: Ischemic Conditioning-High
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger